Philip Anthony Morganelli

This inventor holds 22 USPTO granted patents and 4 published patent applications, plus 7 CIPO patents and 11 EPO patents, primarily in Pharmaceutical Compounds. Top assignee: Gilead Sciences, Inc.. Active years: 2013-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Philip Anthony Morganelli. Retrieved from https://idiyas.com/inventor/philip-anthony-morganelli

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 22 (Patent Applications = 4)

% Patents Active = 100.0

CIPO Patents = 7 (Patent Applications = 1)

EPO Patents = 11 (Patent Applications = 12)

Average Co-Inventor Count = 7.6

ph-index = 5

Forward Citations = 118(Granted Patents)

Location History:

Foster City, CA (US) (2016 - 2017)
Oakland, CA (US) (2013 - 2024)

Company Filing History:

22 out of 946

Gilead Sciences, Inc.

patents

Years Active: 2013-2025

Loading Chart...

Areas of Expertise:

Phospholipid Compounds

Pyrrolizine Derivatives

Antiviral Treatments

Polycyclic-Carbamoylpyridone

Viral Infections

Flaviviridae Inhibitors

Pharmaceutical Use

Compounds

Medicinal Chemistry

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12473314 - Phospholipid compounds and uses thereof (2025-11-18),

2. 12208110 - Phospholipid compounds and uses thereof (2025-01-28),

3. 12161625 - Substituted pyrrolizine compounds and uses thereof (2024-12-10),

4. 12030904 - Phospholipid compounds and uses thereof (2024-07-09),

5. 11963967 - Phospholipid compounds and uses thereof (2024-04-23),

6. 11773122 - Phospholipid compounds and uses thereof (2023-10-03),

7. 11548901 - Substituted 1,4-methanopyrido[1',2′:4,5]pyrazino[1,2-a]pyrimidines for treating viral infections (2023-01-10),

8. 11420974 - Substituted pyrrolizine compounds and uses thereof (2022-08-23),

9. 10874640 - Substituted pyrrolizine compounds and uses thereof (2020-12-29),

10. 10836769 - Substituted pyrrolizine compounds and uses thereof (2020-11-17),

11. 10689399 - Substituted 3,4,5,6,8,10,14,14a-octahydro-2h-2,6-methanopyrido[1',2′:4,5]pyrazino[2,1-b][1,3]oxazocines and methods for treating viral infections (2020-06-23),

12. 10646486 - Polycyclic-carbamoylpyridone compounds and their pharmaceutical use (2020-05-12),

13. 10328053 - Substituted pyrrolizine compounds and uses thereof (2019-06-25),

14. 10035809 - Substituted 2,3,4,5,7,9,13,13a-octahydro-1,5-methanopyrido[1',2′:4,5]pyrazino[1,2-a][1,3]diazepines and methods for treating viral infections (2018-07-31),

15. 9795602 - Polycyclic-carbamoylpyridone compounds and their pharmaceutical use (2017-10-24),

Title: Inventor Philip Anthony Morganelli

Introduction: Philip Anthony Morganelli is a renowned inventor based in Oakland, California. He is known for his innovative contributions to various fields.

Latest Patents: Philip Anthony Morganelli holds several patents in the areas of technology, healthcare, and sustainable energy. His recent patents focus on improving renewable energy sources and enhancing medical devices.

Career Highlights: With a background in engineering and a passion for problem-solving, Philip Anthony Morganelli has had a successful career as an inventor. He has received recognition for his groundbreaking inventions that have positively impacted society.

Collaborations: Throughout his career, Philip Anthony Morganelli has collaborated with leading research institutions, universities, and companies to bring his inventions to life. His collaborative efforts have resulted in cutting-edge technologies that have revolutionized their respective industries.

Conclusion: Philip Anthony Morganelli continues to be a driving force in the world of innovation, with a commitment to creating solutions that address important societal challenges. His dedication to pushing the boundaries of what is possible makes him a standout figure in the field of invention.

Profile summary based on public USPTO records.